Striving for Gold - Laying the Groundwork for the Olympic Healthcare Interoperability Initiative


LAS VEGAS, Nev., March 06, 2018 (GLOBE NEWSWIRE) -- The spirit of health and well-being is core to the founding principles of the Olympic Games and heralds the tenets of sustainable social development within each host and participating country. With the ambitious goal of integrating advanced digital health information sharing into health services provided before, during, and after the Games, the Olympic Healthcare Interoperability (OHI) Initiative & OHI Foundation have been formed to aggressively pursue this vision.

OHI, a digital health industry initiative with charter sponsorship from not-for-profit organizations HIMSS and SNOMED International, was created to advance the seamless exchange and use of health information globally through the Olympic Games. Starting with the 2020 Summer Games in Tokyo, OHI's goal is to "showcase the possible" and "implement the real", through the communication of digital health information, for the benefit of the 1,000's of athletes, trainers and staff, volunteers and attendees. With each edition of the Games, a digital health legacy will be crafted to establish a comprehensive, world-wide infrastructure supportive of appropriate access to relevant clinical information...anywhere, at any time.

Utilizing the latest innovations in digital health, OHI will connect pre-Games, person-specific healthcare information with information generated at the Games by Olympic and Host City healthcare service providers, which will flow back around the world with each individual once the Games conclude. OHI's initial scope will include patient identity matching and access to international patient summaries with capacity to include the significant facets of a patient's digital health record over time.  All with the needed security, privacy and consent framework that will ensure appropriate access to all information.

Consider the case of a Jamaican athlete collapsing on the track, showing symptoms of cardiac stress.  Medical personnel at the stadium use an electronic medical record (EMR) system to query the athlete's electronic records from Jamaica, and discover a number of allergies, current medications, and medical conditions to inform a treatment plan. The athlete, requiring a surgical procedure and transferred to the host city's tertiary hospital, is followed by the necessary diagnostic and treatment information via OHI interoperability.  Post surgery, the updated medical record is posted to the athlete's Jamaican EMR system for follow-up medical treatment at home.

As a way to build an Olympic digital health ecosystem that includes all stakeholders willing to specify, prototype and deploy digital health technology, the OHI Foundation has been created as a not-for-profit, charitable organization.  The Foundation itself has no restriction on membership, and welcomes the participation and support of the global digital health community, namely vendors, healthcare providers, industry and standards organizations.

Recognized charter supporters, HIMSS and SNOMED International, lend their commitment to the pursuit of quality and safety improvements through health information technology and standards alike. Hal Wolfe, HIMSS CEO, states that "HIMSS is proud to sponsor the OHI Initiative as a representative of the digital health industry globally.  OHI supports an ecosystem at the Olympic Games that is built on the same standards, products and infrastructures that are being implemented around the world in order to deliver better health through information and technology. our industry is dedicated to the realization of that vision." Don Sweete, CEO, SNOMED International,  echoes that sentiment. "At the core of care delivery is the principle that clinicians can, beyond a shadow of a doubt, rely on available, accessible and unambiguous clinical information at any point of service. Demonstrating this critical relationship at work through OHI and in support of the healthcare program offered at each Olympic Games, we see a forward-looking example made possible by the interoperability of health information."

Michael Nusbaum, OHI's Executive Lead, has been a driving force in realizing the OHI vision. "Launching OHI through this year's HIMSS18 Interoperability Showcase speaks to the promise of global healthcare interoperability delivered through the lens of the Olympic Games, and for the benefit of participants, national teams, and host countries."

Interested parties can learn more about this initiative at a presentation and drinks reception Tuesday March 6, 4:30pm - 5:30pm  at the HIMSS Interoperability Showcase Theatre, and at an educational session Wednesday March 7th, 1:00pm - 2:00pm in Murano 3301.  Organizations and individuals interested in becoming an OHI Foundation partner are invited to visit the OHI kiosk at the Interoperability Showcase.

About OHI:
OHI, the Olympic Healthcare Interoperability Initiative, began early in 2017 to advance the seamless exchange and use of health information globally, leveraging the 2-year cadence of the Olympic Games and established international standards. Utilizing the latest innovations in digital health, OHI will connect pre-Games person-specific healthcare information with information generated at Games time by Olympic and Host City healthcare service providers: from athletes to staff/officials to volunteers to spectators.

The OHI Foundation is a not-for-profit, charitable organization based in the U.S. The Foundation provides the facilitation and management services required to progress its vision of advancing the use of digital health technology in conjunction with the Olympic Games to impact the health of individuals around the world. 


A photo accompanying this announcement is available at

A photo accompanying this announcement is available at

Michael Nusbaum
Olympic Healthcare Interoperability Initiative 
+1 (250) 384-0001

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Olympic Healthcare Interoperability Initiative via Globenewswire




Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Auth0 Announces Key Distribution Partnership with AppXite20.3.2018 10:00Pressmeddelande

End-to-end identity management now available to all AppXite resellers LONDON, March 20, 2018 (GLOBE NEWSWIRE) -- Auth0, a global leader in Identity-as-a-Service (IDaaS), has announced a new partnership with AppXite, a global leader in SaaS solutions aggregation and fully owned subsidiary of Atea. Auth0's identity and access management platform will be added to AppXite's SaaS offering, adding even more value to its global reseller offering. Auth0's Universal Identity platform will now be accessible to AppXite's extensive global network of managed service providers (MSPs), value-added resellers (VARs), and systems integrators (SIs) around the world. AppXite's reseller network can integrate Auth0's identity platform into their own offering to increase profitability, expand market share, and help their customers thrive in today's cloud economy. "Over the past few years, we have noticed a marked increase in demand for identity management. Companies are realizing the complexity of trying to

McDonald's Becomes the First Restaurant Company to Set Approved Science Based Target to Reduce Greenhouse Gas Emissions20.3.2018 09:03Pressmeddelande

Company Expected to Prevent 150 Million Metric Tons of Emissions by 2030 OAK BROOK, Ill., March 20, 2018 (GLOBE NEWSWIRE) -- Today, McDonald's announces it will partner with franchisees and suppliers to reduce greenhouse gas emissions related to McDonald's restaurants and offices by 36% by 2030 from a 2015 base year in a new strategy to address global climate change. Additionally, McDonald's commits to a 31% reduction in emissions intensity (per metric ton of food and packaging) across its supply chain by 2030 from 2015 levels. This combined target has been approved by the Science Based Targets initiative(SBTi). Through these actions, McDonald's expects to prevent 150 million metric tons of greenhouse gas emissions from being released into the atmosphere by 2030. This is the equivalent of taking 32 million passenger cars off the road for an entire year or planting 3.8 billion trees and growing them for 10 years. The target will enable McDonald's to grow as a business without growing it

Momentum Group acquires Reklamproffsen in Örebro20.3.2018 08:45Pressmeddelande

Momentum Group AB (publ) has acquired 70 percent of the shares in Reklamproffsen Skandinavien AB ("Reklamproffsen"). Reklamproffsen is a leading reseller of promotional products, including workwear and profile clothing, in Örebro and the surrounding area. Reklamproffsen generates annual revenue of approximately MSEK 35 with favourable profitability and has 12 employees. Reklamproffsen is one of Örebro's largest resellers of workwear and profile clothing, with a high level of expertise in customising company products. Reklamproffsen has a professional store and showroom in Örebro. Its customers mainly comprise industrial and service companies, and a significant portion of its sales are conducted via customised online stores. "Thanks to its strong customer and supplier relationships and highly skilled employees, Reklamproffsen has achieved successful growth since it was formed in 2000. It is now a well-established company in Örebro and the surrounding area. We anticipate good opportuniti

Momentum Group förvärvar Reklamproffsen i Örebro20.3.2018 08:45Pressmeddelande

Momentum Group AB (publ) har förvärvat 70 procent av aktierna i Reklamproffsen Skandinavien AB ("Reklamproffsen"). Reklamproffsen är en ledande återförsäljare av produktmedia innefattande yrkeskläder och profilkläder i Örebro med omnejd. Reklamproffsen omsätter cirka 35 MSEK per år med god lönsamhet och har 12 anställda. Reklamproffsen är en av Örebros största återförsäljare inom yrkeskläder och profilkläder med hög kompetens inom företagsprofilering. Reklamproffsen har en yrkesbutik och utställning i Örebro. Kunderna utgörs främst av industri- och serviceföretag och en betydande andel av försäljningen sker via kundunika webbshoppar. - Reklamproffsen har med sina starka kund- och leverantörsrelationer och medarbetare med hög kompetens utvecklats framgångsrikt ända sedan starten år 2000. Bolaget är idag ett väletablerat företag i Örebro med omnejd. Vi ser mycket goda möjligheter till vidare utveckling och tillväxt för Reklamproffsen som en del av Momentum Group, säger Ulf Lilius, VD & K

Immunicum AB: Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical Data20.3.2018 08:00Pressmeddelande

Press Release 20 March 2018 Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical Data Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, announced today that its lead product candidate, ilixadencel, has been granted an Advanced Therapy Medicinal Product (ATMP) certificate following a review of manufacturing quality and non-clinical data by the European Medicines Agency (EMA). "The EMA ATMP certificate is an important development milestone for ilixadencel because it validates our manufacturing quality and preclinical data and gives us a firm foundation for the later stages of clinical development. Cell-based therapies must meet very high requirements and we are pleased to have this recognition from the EMA of our work to date," said Carlos de Sousa, CEO of Immunicum. "Immunicum is one of very few companies that have successfully u

Immunicum AB: Immunicum AB (publ) meddelar att ilixadencel har beviljats ATMP-certifiering från EMA gällande tillverkningskvalitet och prekliniska data20.3.2018 08:00Pressmeddelande

Pressmeddelande 20 mars 2018 Immunicum AB (publ) meddelar att ilixadencel har beviljats ATMP-certifiering från EMA gällande tillverkningskvalitet och prekliniska data Immunicum AB (publ; IMMU.ST) ett bioteknikbolag som utvecklar nya immunostimulerande cancerbehandlingar för ett antal solida tumörformer, meddelar idag att bolagets ledande produktkandidat, ilixadencel, har erhållit en ATMP-certifiering (Advanced Therapy Medicinal Product) efter granskning av tillverkningskvalitet och prekliniska data av den europeiska läkemedelsmyndigheten EMA (European Medicines Agency). "EMAs ATMP certifikat är en viktig milstolpe i utvecklingen av ilixadencel eftersom det validerar vår tillverkningskvalitet och våra prekliniska data, och ger oss samtidigt en solid bas för de senare faserna i den kliniska utvecklingen. Cell-baserade terapier måste uppfylla mycket höga krav och vi är glada att få detta erkännande av EMA för vårt arbete så här långt," säger Carlos de Sousa, VD för Immunicum. "Immunicum ä

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum